<DOC>
	<DOCNO>NCT00290134</DOCNO>
	<brief_summary>The purpose study determine whether one fispemifene dose regimen effective placebo treatment hypogonadism old men .</brief_summary>
	<brief_title>A Preliminary Clinical Study Evaluate Fispemifene Treatment Hypogonadism</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Total testosterone level &lt; 240 ng/dL Serum LH FSH level within normal limit Elevated prolactin Evidence Benign Prostatic Hypertrophy History current breast cancer , prostate cancer , abnormal DRE elevate PSA malignancy Clinically significant endocrine/metabolic cardiovascular disease Significant polycythemia</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Hypogonadism</keyword>
	<keyword>Testosterone</keyword>
</DOC>